Key pipeline products

Product

Ph. I

Ph. II

Ph. III

Filed

Approved

Launched

Clinical

feasibility

Dilacor XR

Madopar DR

Xatral OD

Paxil CR

Naproxen

Requip

Undisclosed

Statin NK-104

Foradil

Undisclosed-MDI

Undisclosed-MDI

AD313

Pulmicort HFA-MDI

DepoCyt (US)

DepoCyt (EUR)

DepoMorphine

DepoBupivacaine

Psoraxine

Solaraze (Eur)

Solaraze (US, CAN)

Watson

Roche

Sanofi-Synthelabo

GSK

SkyePharma

GSK

Merck KGaA

Kowa

Licensee

or partner

Novartis

Sepracor

Undisclosed

Arakis

AstraZeneca

Chiron

Elan

SkyePharma

SkyePharma

Astralis

Bioglan

Bioglan

Oral

Inhalation

Injectable

Topical

Undisclosed

Undisclosed

Injectable

RTP

RTP

Baxter

Solubilization

SkyePharma Products

Client Products

Previous slide

Next slide

Back to first slide

View graphic version